Obesity drug

The Head of Novo Nordisk India Sets Sights on 2026 Launch of Wegovy Obesity Drug; The Growing Obesity Drug Market With A $200 Billion Potential

Novo Nordisk is gearing up to introduce its highly successful weight-loss medication, Wegovy, to the Indian market by 2026; the…